Harnessing AI and big data in clinical research

Technological innovations and digital disruptions have long shaped clinical research. The industry continuously seeks to push boundaries for faster drug development, but patient safety, data integrity and regulatory compliance remain paramount.

ICON’s latest survey and white paper, Digital Disruption: Surveying the Industry’s Evolving Landscape, builds upon a 2019 study. Then, blockchain and organ-on-a-chip generated industry buzz. Today, AI enables advancements like remote monitoring and big data analytics. This survey provides insights into attitudes and challenges in digital innovation across the clinical research industry.